Haemonetics HAE Income Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $1.33B-2.0% | $1.32B-4.0% | $1.33B-2.5% | $1.35B+0.9% | $1.36B+4.0% | ||
| $546.44M-10.7% | $535.85M-16.5% | $554.27M-14.1% | $579.77M-8.7% | $611.87M-0.9% | ||
| $787.59M+5.2% | $782.42M+6.9% | $773.59M+8.0% | $766.28M+9.6% | $748.96M+8.3% | ||
| 59%+4.0pp | 59.4%+6.1pp | 58.3%+5.6pp | 56.9%+4.5pp | 55%+2.2pp | ||
| $59.77M-4.7% | $63.63M+5.6% | $65.27M+13.1% | $64.53M+14.8% | $62.72M+15.2% | ||
| $442.42M+1.3% | $436.62M+1.3% | $433.93M-0.5% | $439.26M-1.2% | $436.79M+1.6% | ||
| $111.72M-3.3% | $112.61M-2.1% | $114.25M+4.3% | $115.21M+11.5% | $115.59M+18.9% | ||
| $630.85M+19.7% | $531.33M-3.6% | $530.86M-3.3% | $530.35M-3.3% | $527.14M+0.1% | ||
| —— | $251.09M+39.2% | $242.73M+45.0% | $235.93M+56.3% | $221.82M+34.5% | ||
| -$28.7M-195% | -$23.93M-52.6% | -$25.62M-201% | -$25.41M-536% | -$9.75M+25.1% | ||
| —— | $227.17M+37.9% | $217.11M+36.7% | $210.53M+43.2% | $212.07M+39.6% | ||
| —— | $51.73M+49.2% | $48.92M+39.6% | $47.19M+47.0% | $44.39M+29.4% | ||
| —— | $175.44M+34.9% | $168.19M+35.8% | $163.34M+42.2% | $167.68M+42.6% | ||
| —— | $3.63+42.9% | $3.42+41.9% | $3.27+46.6% | $3.31+44.5% | ||
| —— | $3.65+42.6% | $3.44+41.6% | $3.29+45.6% | $3.33+43.5% | ||
| 190.4M-6.8% | 193.7M-5.4% | 197.4M-4.0% | 201M-2.4% | 204.2M-0.7% | ||
| 189.7M-6.3% | 192.8M-4.9% | 196.3M-3.4% | 199.6M-1.7% | 202.5M-0.1% | ||
| $44M-8.8% | $44.8M-5.5% | $46.1M+9.6% | $47.18M+27.4% | $48.26M+50.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $86.55M+3,520% | $65.51M+1,389% | $44.47M+594% | $23.43M+179% | $2.39M-77.1% | ||
| —— | —— | —— | —— | —— | ||
| $14.88M+314% | -$17.69M— | -$4.86M— | -$2.54M— | -$6.96M— | ||
| -$47.36M-173% | -$38.54M-146% | -$7.36M-110% | $25.18M-62.4% | $64.7M+7.7% | ||
| $35.03M— | —— | —— | —— | —— | ||
| -$180.49M— | —— | —— | —— | —— | ||
| -$179.55M— | —— | —— | —— | —— | ||
| $293.22M+61.4% | $338.84M+162% | $289.04M+238% | $226.54M+66.8% | $181.73M-0.3% | ||
| -$28.7M-195% | -$23.93M-52.6% | -$25.62M-201% | -$25.41M-536% | -$9.75M+25.1% | ||
| $10.73M+7.5% | $6.62M-52.7% | $8.13M-42.1% | $9.87M-16.6% | $9.98M-14.2% | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | —— | ||
| $32.78M-16.5% | $30.76M+1.5% | $32.96M-9.5% | $37.38M+3.5% | $39.28M+3.0% | ||
| -$102K+59.0% | -$116K+64.8% | -$251K-38.7% | -$223K-27.4% | -$249K+74.5% | ||
| $1.38M-94.1% | $3.3M-84.5% | $3.12M-85.5% | $3.65M-82.9% | $23.25M+1,185% | ||
| —— | —— | —— | —— | —— | ||
| —— | $6.25M-5.6% | $6.25M-27.0% | $4.69M-61.1% | $4.69M-61.7% | ||
| —— | —— | —— | —— | —— | ||
| $33.83M+14.1% | $31.64M+5.0% | $32.05M+10.1% | $31.32M+8.1% | $29.64M+4.6% | ||
| —— | $251.09M+39.2% | $242.73M+45.0% | $235.93M+56.3% | $221.82M+34.5% | ||
| —— | $363.7M+23.1% | $356.97M+28.9% | $351.14M+38.1% | $337.4M+28.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Haemonetics's profit margins?
- Gross margin is 59.0% and operating margin is 19.0%, with a 13.3% net margin.
- Where does Haemonetics's income statement data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.